Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Asthma

Recruiting

Registered drugNo placebo

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Placebo

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Breast cancer metastatic

Recruiting

Registered drug

A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Letrozole

Contact Research Centre

Metabolic dysfunction-associated liver disease

Recruiting

Investigational

N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ly3437943 Sodium

Contact Research Centre

Relapsing multiple sclerosis

Recruiting

Registered drug

Study of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis

Registered drug

Poland

Participants:0–17 years
Substances:Fingolimod

Contact Research Centre

Parkinson's disease

Recruiting

Investigational

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Multiple sclerosis

Recruiting

Registered drug

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Registered drug

Poland

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study of icotrokinra for adults with moderately to severely active Crohn's disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:ICOTROKINRA

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:ICOTROKINRA

Contact Research Centre

Clear cell renal cell carcinoma

Recruiting

Registered drug

A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:AB521

Contact Research Centre

Breast cancer+2

Recruiting

Registered drugNo placebo

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Dermatitis atopic

Recruiting

Investigational

A study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ro7790121

Contact Research Centre

Find therapies in clinical trials near you – page 6

339 trials match your criteria

Asthma

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Secondary progressive multiple sclerosis

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Breast cancer metastatic

A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

Metabolic dysfunction-associated liver disease

Relapsing multiple sclerosis

Study of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis

Parkinson's disease

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Multiple sclerosis

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Crohn's disease

Study of icotrokinra for adults with moderately to severely active Crohn's disease

Colitis ulcerative

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Clear cell renal cell carcinoma

A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

Breast cancer+2

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Dermatitis atopic

A study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.